Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
Sponsor: Suleyman Demirel University
Summary
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.
Official title: Lymphocyte to Procalcitonin Ratio: A New Predictor of Prognosis and Mortality in Covid
Key Details
Gender
All
Age Range
23 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
535
Start Date
2020-04-01
Completion Date
2024-12-01
Last Updated
2024-10-03
Healthy Volunteers
No
Conditions
Locations (1)
Süleyman demirel üniversitesi tıp fakültesi
Isparta, Turkey (Türkiye)